340B Lobbying Remained Strong in the Second Quarter of 2025, Filings Show

340B program stakeholders continued to spend big on federal lobbying efforts in the second quarter of 2025.
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Anti-340B Dark Money Group Promotes GOP-Passed Reconciliation Bill in New Ad

Dark money group Building America’s Future released a 30-second ad touting the new reconciliation budget law, which includes massive Medicaid spending cuts.
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital and Pharmacist Groups ask HRSA to Extend 340B Rebate Model Pilot Proposal Timeline

Hospital and pharmacist trade groups asked HRSA Administrator Thomas Engels in an Aug. 8 letter to extend the rebate model pilot proposal's deadlines.
Trade groups representing 340B hospitals and hospital pharmacists recently urged the Health Resources and Services Administration (HRSA) to extend the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sobi, J&J Exempt New States from 340B Contract Pharmacy Restrictions

Drugmakers Sobi and Johnson & Johnson recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access laws.
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Terminates Texas Hospital Location from 340B Program

HRSA recently announced that a site in a Texas health system has been removed from the 340B program.
The Health Resources and Services Administration (HRSA) recently announced that a Texas health system’s location has been removed from the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

HRSA Proposes Changes to STD Clinics and Other 340B Covered Entities’ Recertification and Enrollment Requirements; Extends Date for Rebate Comments

HRSA included updated 340B program enrollment and recertification requirements for covered entities in an Aug. 7 Federal Register notice.
Sexually transmitted disease (STD) clinics and other 340B covered entities must submit new or more complete information to enroll in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

The U.S. 2nd Circuit Court of Appeals' 3-0 decision reversed a lower court’s 2024 ruling that had denied health centers' antitrust claims against four drug manufacturers that have placed contract pharmacy restrictions.
A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live